Comparison of 1.5 Tesla and 3.0 Tesla for skull base lesion enhancement

Journal of the Hong Kong College of Radiologists

Volumn 11, Issue 1, 2008, Pages 19-23

  Londy, F J ^a   Rohrer, S ^a   Kumar, S ^a   Parmar, H ^a   Mukherji, S K ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Gadolinium; Magnetic resonance imaging; Skull base

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

ADULT; ARTICLE; ASPERGILLOSIS; BONE METASTASIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; FEMALE; HUMAN; IMAGE ENHANCEMENT; LYMPHOMA; MALE; MATHEMATICAL MODEL; MELANOMA; MENINGIOMA; NEURILEMOMA; NEURITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PREDICTION; SKULL BASE LESION; SKULL DISEASE; SQUAMOUS CELL CARCINOMA;

EID: 48549107245     PISSN: 10295097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Frayne R, Goodyear BG, Dickoff P, Louzon L, Sevick RJ. Magnetic resonanace imaging at 3.0 Tesla: challenges and advantages in clinical neurologic imaging. Invest Radiol. 2003;38:385-402.
2. Nöbauer-Huhmann IM, Ba-Ssalamah A, Mlynarik V, et al. Magnetic resonance imaging contrast enhancement of brain tumors at 3 Tesla versus 1.5 Tesla. Invest Radiol. 2002;37:114-9.
3. Ginsberg LE. MR imaging of perineural tumor spread. Neuro-imaging Clin N Am. 2004;14:663-77.
4. Chong VF, Khoo JB, Fan YF. Imaging of the nasopharynx and skull base. Neuroimaging Clin N Am. 2004;14:695-719.
5. Lu H, Nagae-Poetscher LM, Golay X, Lin D, Pomper M, van Zijl PC. Routine clinical brain MRI sequences for use at 3.0 Tesla. J Magn Reson Imaging. 2005;22:13-22.
6. Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species and age. Med Phys. 1984;11:425-48.
7. 2 diagnostic? Med Phys. 1987;14:1-37.
8. Bernstein MA, Huston J, Lin C, Gibbs GF, Felmlee JP. High-resolution interacranial and cervical MRA at 3.0T: technical considerations and initial experience. Magn Reson Med. 2001; 46:995-62.
9. Hendrick RE, Haacke EM. Basic physics of MR contrast agents and maximization of image contrast. J Magn Reson Imaging. 1993;3:137-48.
10. Tratting S, Ba-Ssalamah A, Nöbauer-Huhmann IM, et al. MR contrast agent at high-field MRI (3 Tesla). Top Magn Reson Imaging. 2003;14:365-75.
11. Sicotte NL, Voskuhl RR, Bouvier S, Klutch R, Cohen MS, Mazziotta JC. Comparison of multiple sclerosis lesions at 1.5T and 3.0T. Invest Radiol. 2003;38:423-7.
12. Barth M, Nöbauer-Huhmann IM, Reichenbach JR. High-resolution three-dimensional contrast-enhanced blood oxygenation level-dependent magnetic resonance venography of brain tumors at 3 tesla: first clinical experience and comparison with 1.5 tesla. Invest Radiol. 2003;38:409-14.